期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Pharmacokinetics of recombinant human interleukin-3 in rhesus monkeys
1
作者 汤仲明 刘秀文 屠敏 《Science China(Life Sciences)》 SCIE CAS 1997年第5期546-553,共8页
Concentration-time profiles of <sup>125</sup>I-labeled recombinant human interleukin-3 (125IrhIL-3) were de-termined by reverse phase high performance liquid chromatography (RHPLC) after intravenous an... Concentration-time profiles of <sup>125</sup>I-labeled recombinant human interleukin-3 (125IrhIL-3) were de-termined by reverse phase high performance liquid chromatography (RHPLC) after intravenous and subcutaneous ad-ministration of the drug in 16 rhesus monkeys. The initial and terminal T1/2 in plasma after intravenous of 30 μg/kg were (0. 15 ±0.13) and (2. 21 ± 0. 59) h, respectively. Terminal half-lives after 30, 90 and 180μg/kg subcutaneous (s.c.) injections were 2. 0-3.8 h. Area under concentration-time curves (AUC) following s. c. were roughly in-creased with dose, while CL5 were similar among different dosages. The absorption rates were dependent on concentra-tion at injected site. Bioavailability was about 0.7 after s.c. Rapid biodegradation was found in plasma. Distribution profiles of total radioactivity were as follows: the highest level was found in urinary system; levels in bile-enteric sys-tem, lymph nodes, bone marrow and spleen were near to that in plasma, and level in brain was the 展开更多
关键词 recombinant human interleukin-3 rhesus monkey pharmacokinetics 125l-labeling high perfor-mace liquid chromatography.
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部